ArticleACS omega2026
DGSite: A Well-Calibrated Deep Learning Framework for Protein-RNA Binding Site Prediction.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-RNA interactions play pivotal roles in biological processes. Despite the development of numerous computational models for protein-RNA binding site prediction, they still face critical challenges, including insufficient integration of global and local features, class imbalance undermining precision-recall, and poorly calibrated predictions. To address these issues, we first constructed a larger and more comprehensive data set (Train-1086 and Test-107). Specifically, we developed DGSite, a novel deep learning framework that captures long-range dependencies via the simplified Deformable Attention Transformer and extracts multiscale local contextual features using Graph Attention Networks. To mitigate class imbalance and reduce model uncertainty, we introduced Adaptive Bias Loss (ABL), based on optimal transport theory. On this foundation, we proposed a hybrid loss function, ABL+FL, that adaptively combines the complementary strengths of ABL and Focal Loss (FL) to achieve a superior balance between precision, recall, and calibration. Extensive experiments demonstrated that DGSite achieves high performance on both Test-107 and established classic data sets. The ABL+FL loss not only balanced precision and recall but also significantly reduced model uncertainty, yielding well-calibrated and more trustworthy predictions. Moreover, case-study visualizations confirmed the model's ability to minimize false positives and provide interpretable insights. Collectively, DGSite serves as a robust, high-performance, and well-calibrated computational tool for pinpointing protein-RNA binding sites.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.